IJE Advance Access originally published online on October 28, 2005
International Journal of Epidemiology 2006 35(1):159-166; doi:10.1093/ije/dyi223
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
Weight history and risk of endometrial cancer among Chinese women
1 Department of Epidemiology, Shanghai Cancer Institute, Cancer Institute of Shanghai Jiaotong University, 2200/25 Xie Tu Road, Shanghai 200032, P. R. C
2 Department of Medicine, Center for Health Services Research, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville TN 37232-8300, USA
* Corresponding author. Center for Health Services Research, 6009 Medical Center East, Vanderbilt University, 1215 21st Ave South, Nashville TN 37232-8300, USA. E-mail: Xiao-Ou.Shu{at}vanderbilt.edu
Background Adult obesity is a well-established risk factor for endometrial cancer. However, little is known about the association of endometrial cancer risk with body size early in life and weight change during adulthood. We investigated whether women with greater early-age body size or with greater weight change during adulthood have an increased risk of endometrial cancer.
Methods We analysed data from a population-based case–control study of endometrial cancer conducted between 1997 and 2001 in Shanghai, China. Included in this analysis were 832 endometrial cancer cases aged 30–69 years and 846 population controls. Information on weight and height history from adolescence through adulthood was obtained via structured in-person interviews. A logistic regression model was used to derive odds ratios (ORs) and 95% confidence intervals (CIs) for endometrial cancer in association with adolescent and adult adiposity, as well as adult body weight change. All ORs were adjusted for age, education, menstrual status, duration of menstruation, number of pregnancies, oral contraceptive use, and family history of cancer.
Results Perceived weights and heights during puberty that were greater than average were associated with a modestly increased risk of cancer. The association for perceived weight was substantially weakened after adjustment for current body mass index (BMI). High BMI at all adult ages significantly predicted endometrial cancer risk, with recent BMI being the strongest predictor. Further analyses disclosed that weight gain during adulthood, particularly during the peri-menopausal period (age 40–50 years), was associated with a significantly elevated risk of endometrial cancer, even among currently non-obese women. Gaining >5 kg between age 40 and 50 was related to ORs of 2.3 (95% CI 1.4–3.9) for women with a BMI < 25 kg/m2 and 2.0 (95% CI 1.3–3.0) for women with BMI 
25 kg/m2.
Conclusions Adult weight gain, particularly during the peri-menopausal period, plays a significant role in the development of endometrial cancer risk.
Keywords Endometrial cancer, weight gain, obesity
Accepted 29 September 2005
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H.-L. Xu, W.-H. Xu, Q. Cai, M. Feng, J. Long, W. Zheng, Y.-B. Xiang, and X.-O. Shu Polymorphisms and Haplotypes in the Caspase-3, Caspase-7, and Caspase-8 Genes and Risk for Endometrial Cancer: A Population-Based, Case-Control Study in a Chinese Population Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2114 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rapp, J. Klenk, H. Ulmer, H. Concin, G. Diem, W. Oberaigner, and J. Schroeder Weight change and cancer risk in a cohort of more than 65 000 adults in Austria Ann. Onc., April 1, 2008; 19(4): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Rodriguez, B.J. Rimel, W. Watkin, J. M. Turbov, C. Barry, H. Du, G. L. Maxwell, and J.M. Cline Progestin Treatment Induces Apoptosis and Modulates Transforming Growth Factor-{beta} in the Uterine Endometrium Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 578 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lane Obesity and gynaecological cancer Menopause Int, March 1, 2008; 14(1): 33 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. McCullough, A. V. Patel, R. Patel, C. Rodriguez, H. S. Feigelson, E. V. Bandera, T. Gansler, M. J. Thun, and E. E. Calle Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 73 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Chang, J. V. Lacey Jr., L. A. Brinton, P. Hartge, K. Adams, T. Mouw, L. Carroll, A. Hollenbeck, A. Schatzkin, and M. F. Leitzmann Lifetime Weight History and Endometrial Cancer Risk by Type of Menopausal Hormone Use in the NIH-AARP Diet and Health Study Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cowey and R. W. Hardy The Metabolic Syndrome: A High-Risk State for Cancer? Am. J. Pathol., November 1, 2006; 169(5): 1505 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M Webb Commentary: Weight gain, weight loss, and endometrial cancer Int. J. Epidemiol., February 1, 2006; 35(1): 166 - 168. [Full Text] [PDF]
|
|